Delivery Order SPE2DB24D1205-SPE2DB25FCQZY

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The $3,695.24 firm-fixed-price contract has an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,262.23 and a period of performance through December 13, 2023. This Delivery Order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,834.90 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S. The contract has an ultimate completion date of May 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price ceiling value of $3,826.35 and an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any small business category. The contract is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LAMICTAL XR 200 MG TABLET 30S, a medical product, with an ultimate completion date of September 22, 2023 and a ceiling value of $9,992.98. The contract is a firm fixed price delivery order with no set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The firm-fixed-price contract has a ceiling value of $5,814.13 and a completion date of June 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,823.26, is for the delivery of 4567472003 ! LAMICTAL XR 100 MG TABLET 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,009.57, is for the delivery of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,284.03, is for the delivery of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation noted for...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCQZY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LAMICTAL XR 250 MG TABLET 30S. The $13,637.86 firm fixed price contract has an ultimate completion date of October 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare procurement, particularly within the military and veterans' health systems.

Generated 1/22/25, 12:55 AM